A detailed history of Baldrige Asset Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Baldrige Asset Management LLC holds 2,155 shares of JNJ stock, worth $334,111. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,155
Previous 2,266 4.9%
Holding current value
$334,111
Previous $400,000 16.5%
% of portfolio
0.14%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$151.05 - $180.26 $16,766 - $20,008
-111 Reduced 4.9%
2,155 $334,000
Q4 2022

Jan 13, 2023

BUY
$160.2 - $179.79 $21,466 - $24,091
134 Added 6.29%
2,266 $400,000
Q3 2022

Oct 13, 2022

SELL
$161.33 - $179.52 $9,518 - $10,591
-59 Reduced 2.69%
2,132 $348,000
Q2 2022

Jul 12, 2022

SELL
$168.19 - $186.01 $11,268 - $12,462
-67 Reduced 2.97%
2,191 $389,000
Q1 2022

Apr 26, 2022

SELL
$158.14 - $179.59 $18,027 - $20,473
-114 Reduced 4.81%
2,258 $400,000
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $8,732 - $9,688
-56 Reduced 2.31%
2,372 $406,000
Q3 2021

Oct 22, 2021

SELL
$161.5 - $179.47 $14,050 - $15,613
-87 Reduced 3.46%
2,428 $392,000
Q2 2021

Aug 03, 2021

SELL
$159.48 - $171.07 $15,947 - $17,107
-100 Reduced 3.82%
2,515 $414,000
Q1 2021

Apr 14, 2021

SELL
$153.07 - $170.48 $15,766 - $17,559
-103 Reduced 3.79%
2,615 $430,000
Q4 2020

Feb 03, 2021

BUY
$137.11 - $157.38 $5,484 - $6,295
40 Added 1.49%
2,718 $428,000
Q2 2020

Jul 31, 2020

BUY
$128.81 - $155.51 $10,433 - $12,596
81 Added 3.12%
2,678 $377,000
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $16,192 - $18,597
-127 Reduced 4.66%
2,597 $379,000
Q3 2019

Oct 23, 2019

SELL
$126.95 - $142.14 $18,788 - $21,036
-148 Reduced 5.15%
2,724 $352,000
Q2 2019

Jul 18, 2019

SELL
$131.15 - $144.24 $9,442 - $10,385
-72 Reduced 2.45%
2,872 $400,000
Q1 2019

May 16, 2019

BUY
$125.72 - $139.79 $370,119 - $411,541
2,944 New
2,944 $412,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Baldrige Asset Management LLC Portfolio

Follow Baldrige Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldrige Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldrige Asset Management LLC with notifications on news.